Annual report

Period2023-04-01 → 2024-03-31
Filed2024-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed
Key figures · 104
MetricValuePeriodScopeSource row
Revenue¥8.3bn2023-04-01 → 2024-03-31Cons.Net sales
Operating income¥711m2023-04-01 → 2024-03-31Cons.Operating income
Ordinary income¥717m2023-04-01 → 2024-03-31Cons.Ordinary income
Profit before tax¥655m2023-04-01 → 2024-03-31Cons.Income before income taxes
Net income (owners)¥441m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income¥441m2023-04-01 → 2024-03-31Cons.Profit loss
Total assets¥6.4bnat 2024-03-31Cons.Assets
Total liabilities¥4.7bnat 2024-03-31Cons.Liabilities
Net assets / equity¥1.6bnat 2024-03-31Cons.Net assets
Net assets / equity¥1.5bnat 2023-03-31Cons.Net assets
Cash and deposits¥688mat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥688mat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥568mat 2023-03-31Cons.Cash and cash equivalents
Operating cash flow¥707m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Financing cash flow¥539m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥62.052023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥59.262023-04-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥231.46at 2024-03-31Cons.Net assets per share (5-year summary)
Equity ratio25.9%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
ROE26.8%2023-04-01 → 2024-03-31Cons.Rate of return on equity (5-year summary)
Employees544at 2024-03-31Cons.Number of employees
Revenue¥8.3bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥6.7bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥5.8bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥5.1bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥4.3bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Operating income¥707m2023-04-01 → 2024-03-31StandaloneOperating income
Operating income¥530m2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income¥719m2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥558m2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥506m2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥251m2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥122m2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥655m2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax¥534m2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income¥441m2023-04-01 → 2024-03-31StandaloneProfit loss
Net income¥383m2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥328m2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income¥97m2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥33m2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥4.4bnat 2024-03-31StandaloneAssets
Total assets¥2.9bnat 2023-03-31StandaloneAssets
Total assets¥2.5bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.0bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.8bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥2.8bnat 2024-03-31StandaloneLiabilities
Total liabilities¥1.4bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.6bnat 2024-03-31StandaloneNet assets
Net assets / equity¥1.5bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.1bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥609mat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥503mat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥661mat 2024-03-31StandaloneCash and deposits
Cash and deposits¥568mat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥568mat 2023-03-31StandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥720mat 2022-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥538mat 2021-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥227mat 2020-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥342m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥485m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥352m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥35m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥383m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥320m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥78m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥165m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥111m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥17m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥37m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥6m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥62.062023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.922022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥47.92021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥28.992020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥9.92019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥59.282023-04-01 → 2024-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥50.822022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥43.322021-04-01 → 2022-03-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥231.48at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥207.61at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥153.22at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥178.69at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥151.36at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio37.0%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio42.4%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio30.2%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio28.4%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE28.2%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE30.0%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE39.1%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE17.5%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE6.8%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued7,246,000at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,572,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,499,100at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued11,369at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued11,074at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees544at 2024-03-31StandaloneNumber of employees
Employees442at 2023-03-31StandaloneNumber of employees
Employees329at 2022-03-31dStandaloneNumber of employees
Employees312at 2021-03-31dStandaloneNumber of employees
Employees283at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 48
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2023-04-01 → 2024-03-31¥5m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2023-04-01 → 2024-03-31¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2024-03-3118 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2024-03-31¥35m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2024-03-31¥35m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2024-03-31¥61m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2024-03-31−¥9m
Reconciling Itemsreconcilingcapex2023-04-01 → 2024-03-31¥8m
Reconciling Itemsreconcilingdepreciation2023-04-01 → 2024-03-31¥8m
Reconciling Itemsreconcilingsegment assetsat 2024-03-31¥854m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2024-03-31−¥409m
Home Visit Pharmacist Servicereportable segmentcapex2023-04-01 → 2024-03-31¥317m
Home Visit Pharmacist Servicereportable segmentdepreciation2023-04-01 → 2024-03-31¥84m
Home Visit Pharmacist Servicereportable segmentemployeesat 2024-03-31323 pure
Home Visit Pharmacist Servicereportable segmentrevenue2023-04-01 → 2024-03-31¥6.5bn
Home Visit Pharmacist Servicereportable segmentrevenue external2023-04-01 → 2024-03-31¥6.5bn
Home Visit Pharmacist Servicereportable segmentsegment assetsat 2024-03-31¥2.0bn
Home Visit Pharmacist Servicereportable segmentsegment profit2023-04-01 → 2024-03-31¥635m
Kirari Primereportable segmentcapex2023-04-01 → 2024-03-31¥116m
Kirari Primereportable segmentdepreciation2023-04-01 → 2024-03-31¥26m
Kirari Primereportable segmentemployeesat 2024-03-3127 pure
Kirari Primereportable segmentrevenue2023-04-01 → 2024-03-31¥837m
Kirari Primereportable segmentrevenue external2023-04-01 → 2024-03-31¥837m
Kirari Primereportable segmentsegment assetsat 2024-03-31¥238m
Kirari Primereportable segmentsegment profit2023-04-01 → 2024-03-31¥485m
Primary Care Homereportable segmentcapex2023-04-01 → 2024-03-31¥113m
Primary Care Homereportable segmentdepreciation2023-04-01 → 2024-03-31¥50m
Primary Care Homereportable segmentemployeesat 2024-03-31138 pure
Primary Care Homereportable segmentrevenue2023-04-01 → 2024-03-31¥883m
Primary Care Homereportable segmentrevenue external2023-04-01 → 2024-03-31¥883m
Primary Care Homereportable segmentsegment assetsat 2024-03-31¥3.2bn
Primary Care Homereportable segmentsegment profit2023-04-01 → 2024-03-31¥8m
—segment totalcapex2023-04-01 → 2024-03-31¥546m
—segment totaldepreciation2023-04-01 → 2024-03-31¥160m
—segment totalrevenue2023-04-01 → 2024-03-31¥8.3bn
—segment totalrevenue external2023-04-01 → 2024-03-31¥8.3bn
—segment totalsegment assetsat 2024-03-31¥5.4bn
—segment totalsegment profit2023-04-01 → 2024-03-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalcapex2023-04-01 → 2024-03-31¥552m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-04-01 → 2024-03-31¥166m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2024-03-31¥8.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2024-03-31¥8.3bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-03-31¥5.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2024-03-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2024-03-3118 pure
Home Visit Pharmacist Servicereportable segmentemployeesat 2024-03-31323 pure
Kirari Primereportable segmentemployeesat 2024-03-3127 pure
Primary Care Homereportable segmentemployeesat 2024-03-31138 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,145
ItemContextValueUnit
Cost of salesCurrentYearDuration_NonConsolidatedMember6404904000JPY
Gross profitPrior1YearDuration_NonConsolidatedMember1562555000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember1880049000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember1032256000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember1172714000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember530298000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember707335000JPY
Interest income noiPrior1YearDuration_NonConsolidatedMember7000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember1977000JPY
Subsidy income noiPrior1YearDuration_NonConsolidatedMember25864000JPY
Subsidy income noiCurrentYearDuration_NonConsolidatedMember13200000JPY
Other noiPrior1YearDuration_NonConsolidatedMember3907000JPY
Other noiCurrentYearDuration_NonConsolidatedMember1750000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember29778000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember16928000JPY
Interest expenses noePrior1YearDuration_NonConsolidatedMember2032000JPY
Interest expenses noeCurrentYearDuration_NonConsolidatedMember5354000JPY
Other noePrior1YearDuration_NonConsolidatedMember293000JPY
Other noeCurrentYearDuration_NonConsolidatedMember101000JPY
Non operating expensesPrior1YearDuration_NonConsolidatedMember2326000JPY
Non operating expensesCurrentYearDuration_NonConsolidatedMember5456000JPY
Ordinary incomePrior1YearDuration_NonConsolidatedMember557751000JPY
Ordinary incomeCurrentYearDuration_NonConsolidatedMember718807000JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember23703000JPY
Impairment loss elCurrentYearDuration_NonConsolidatedMember63977000JPY
Extraordinary lossPrior1YearDuration_NonConsolidatedMember23703000JPY
Extraordinary lossCurrentYearDuration_NonConsolidatedMember63977000JPY
Income before income taxesPrior1YearDuration_NonConsolidatedMember534047000JPY
Income before income taxesCurrentYearDuration_NonConsolidatedMember654829000JPY
Income taxes currentPrior1YearDuration_NonConsolidatedMember141838000JPY
Income taxes currentCurrentYearDuration_NonConsolidatedMember229817000JPY
Income taxes deferredPrior1YearDuration_NonConsolidatedMember9332000JPY
Income taxes deferredCurrentYearDuration_NonConsolidatedMember-16124000JPY
Income taxesPrior1YearDuration_NonConsolidatedMember151170000JPY
Income taxesCurrentYearDuration_NonConsolidatedMember213693000JPY
Profit lossPrior1YearDuration_NonConsolidatedMember382876000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember441136000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_CapitalStockMember171915000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_LegalCapitalSurplusMember311920000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_OtherCapitalSurplusMember10005000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_CapitalSurplusMember321925000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_GeneralReserveMember9081000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember569342000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_RetainedEarningsMember578423000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_TreasuryStockMember-JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_ShareholdersEquityMember1072264000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember1072264000JPY
Issuance of new sharesexercise of subscription rights to sharesPrior1YearDuration_NonConsolidatedMember_CapitalStockMember13996000JPY
Issuance of new sharesexercise of subscription rights to sharesPrior1YearDuration_NonConsolidatedMember_LegalCapitalSurplusMember13996000JPY
Issuance of new sharesexercise of subscription rights to sharesPrior1YearDuration_NonConsolidatedMember_CapitalSurplusMember13996000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 17 of 17 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass